DarioHealth Prices $23.5 Million Stock Offering at Market Value
DarioHealth Corp. announced in a press release that it has priced a registered direct offering of approximately $23.5 million in common stock at $6.80 per share. The offering involves the sale of 3,454,559 shares to existing institutional investors and new participants.
A member of DarioHealth's board of directors also took part, purchasing 14,430 shares at $6.93 per share. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction.
Gross proceeds from the offering are expected to be about $23.5 million before fees and expenses. The closing is anticipated on or about July 23, 2026, subject to standard closing conditions. DarioHealth plans to use the funds for working capital, investments, acquisitions, and general corporate purposes.
The securities are being issued under an effective shelf registration statement on Form S-3 (File No. 333-294454) that became effective on March 27, 2026. A prospectus supplement will be filed with the U.S. Securities and Exchange Commission and made available through its website.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030More from Life Sciences
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 Mosaic Raises $47M for Blood Vessel Surgery Robots Nov 11 Kardi AI Raises €5.3 Million for Heart Monitoring Expansion Nov 11 Switchpoint Bio raises $5.3 million for AI epigenomics platform Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and OptumLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Anthropic seeks up to $64.4 billion in IPO priced at $70 to $78 a share
Hyperscale Data Plans $33.5 Million Tokenized Preferred Stock Offering
Anthropic spent $2.75 million on Dario Amodei's security in 2025
Anthropic Founders Could Each Sell About $250 Million in IPO Stock
Anthropic IPO Bankers Prepare for $1.5 Trillion Valuation After Orders Cover Offering, FT Reports
Daily AI Brief: the AI news that matters, in your inbox.